WeVote

Bill

Bill

A 3959

Regulates residential mental health treatment facilities.

2024-2025 Regular Session Introduced by John Azzariti and 2 co-sponsors

Creates a standalone license with minimum ASAM Level 3.5 standards for NJ residential mental health facilities, exempt from the CON process.

Introduced in the Assembly, Referred to Assembly Health Committee
0
WeVote Research Nonpartisan
Bill Summary · A 3959

Summary — A3959 (Introduced): Regulation of Residential Mental Health Treatment Facilities

Status and sponsors
- Introduced in the Assembly; referred to the Assembly Health Committee. Primary sponsor: Assemblymember Carrie Woerner. Cosponsors include Chris Burdick, Deborah Glick, Jodi Giglio, Rebecca Kassay, Marianne Buttenschon, and Yudelka Tapia. Related/companion bills: S2555 and S8095. Introduced January 30, 2025 (bill text supplements Title 26, P.L.1992, c.160).

Purpose
- Establish a new, standalone licensing and regulatory framework for "residential mental health treatment facilities" in New Jersey, set minimum standards of care, and exempt those facilities from the State certificate-of-need (CON) requirement.

Key definitions
- Commissioner: Commissioner of Health.
- Mental health condition: Defined by the most current edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) consistent with current medical practice.
- Patient: Person with a mental health condition or substance-related impairment who requires continuing residential care.
- Residential mental health treatment facility: Facility or distinct part of a facility providing 24+ hour residential diagnosis/care/treatment for two or more unrelated patients through a structured recovery environment with professional clinical services. Includes facilities for adolescents, adults, persons with dependent children, extended/long-term/short-term residential care. Excludes residential substance use disorder programs (defined elsewhere) and hospital-based mental health stabilization programs licensed under Title 30.

Main provisions
- Required standard of care: Facilities must provide care consistent with the American Society of Addiction Medicine (ASAM) Level 3.5 standard — a 24/7 structured living environment for patients who need that support and when inpatient hospitalization is unnecessary.
- Treatment goals: Provide time-limited services aimed at preparing patients to transition to lower levels of care.
- Prohibits retrospective or concurrent review of medical necessity for services provided by the facility (i.e., facilities must provide services without retrospective/concurrent medical necessity review).
- Licensing: All such facilities must be licensed by the Commissioner of Health. Applications must include facility location, owner names, facility description, evidence of ability to meet minimum standards, and evidence of owners' good moral character. Licenses are non-transferable and must be displayed.
- Co-location prohibition: A residential mental health treatment facility may not be licensed at the same physical location as a residential substance use disorders treatment facility/program.
- Regulations: The Commissioner must adopt rules establishing minimum licensure and treatment standards within 90 days after the bill’s effective date, using, where feasible, a structure similar to existing residential substance use disorder regulations (N.J.A.C. 8:111).

Procedural change (CON)
- Amends P.L.1992, c.160 to add residential mental health treatment facilities to the list of facility types exempt from the State certificate-of-need process.

Who is affected
- Patients with mental health conditions receiving or seeking residential care.
- Owners/operators of residential mental health treatment facilities (new licensing obligations and standards).
- Department of Health (rulemaking, licensing, oversight).
- Payers and insurers (the bill’s prohibition on retrospective/concurrent medical-necessity review could alter claim review and reimbursement practices).

Potential impacts and considerations
- Creates a clear licensing pathway and standards for residential mental health treatment but may raise reimbursement and utilization-management issues because of the ban on retrospective/concurrent medical necessity reviews.
- Regulatory timeline: Commissioner-directed rulemaking within 90 days of enactment; implementation details will depend on the forthcoming administrative rules.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.